Category: Featured Story

A drug developed to treat bile duct cancer, a rare disease that strikes 2,000 – 3,000 Americans each year, will be closely watched by the mesothelioma community as it enters Phase 3 trials in several countries, including the U.S. Phase 3 trials enroll more patient volunteers than in Phase 2, where an experimental drug is …

Mesothelioma patients will soon have access to a new treatment through a clinical trial thanks to a recent discovery by Australian researchers. The researchers found a way to shut down a tumor’s “life support system” by using an antibody to attack the protein Epha3. A team of researchers from Australia found that by targeting Epha3, …

Targeting biomarkers, or the unique identifying genetic traits of tumors, in the treatment of lung cancer is touted as the best way to attack the aggressive cancer. However, researchers are now reporting that unless the cancer is identified and treated early, multiple biomarkers take over the tumors leaving many of the cancer cells unaffected by …